Keywords
cleroderma-like skin changes
How to Cite
Abstract
Abstract: Taxanes (paclitaxel, docetaxel) are antineoplastic agents used in advanced ovarian, breast, lung, head and neck cancer. Diverse cutaneous adverse reactions associated with taxane administration have been reported such as bullous eruption, onycholysis, acral erythema, erythema multiforme, pustular eruption, scleroderma-like skin changes of both upper and lower extremities. Here, we report a case of 48-year-old female patient, who presented for consultation with rheumatologist with complaints of hand and finger oedema and stiffness. Oedema and mild skin thickening of the fingers and hands were evident at physical examination. Inflammatory joint pain, synovitis, Raynaud’s phenomenon and trophic changes were not present. Standard laboratory tests i.e., complete blood count and biochemistry tests were within normal values. The patient was euthyroid. Immunological tests were negative (antinuclear antibodies; antibodies against extractable nuclear antigens – dsDNA, Sm, RNP, Scl-70; antiphospholipid antibodies – anticardiolipin, anti-beta-2-glycoprotein; anti-CCP antibody and rheumatoid factor). Capillaroscopic examination did not reveal signs of microangiopathy. Skin biopsy was perfomed in the area of a proximal phalanx and the histological examination revealed dermal oedema and superficial scant perivascular infiltrate containing lymphocytes and histiocytes. The patient had undergone an operation for breast cancer 13 years ago and subsequent second operation because of cancer recurrence 7 years ago. After the second operation chemotherapy was performed that included 1 cycle with paclitaxel and 4 cycles with docetaxel. The analysis of the case led to the conclusion that the scleroderma-like skin changes of the fingers and hands are induced by taxane administration in the past. The patient received corticosteroid treatment for 7 months with gradual resolution of symptoms.
References
Hamaguchi Y. Drug-induced scleroderma-like lesion. Allergol Int. 2022;71(2):163–8.
Dumont A, Dolladille C, de Boysson H, Alexandre J, Nguyen A, Deshayes S, et al. Drugs associated with systemic sclerosis: An updated list of suspected drugs using the WHO pharmacovigilance database. Autoimmun Rev. 2022;21(9).
Kupfer I, Balguerie X, Courville P, Chinet P, Joly P. Scleroderma-like cutaneous lesions induced by paclitaxel: A case study. J Am Acad Dermatol. 2003;48(2 SUPPL.):279–81.
Battafarano DF, Zimmerman GC, Older SA, Keeling JH, Burn’s HA. Docetaxel (Taxotere) associated scleroderma‐like changes of the lower extremities. A report of three cases. Cancer. 1995;76(1):110–5.
Verhulst L, Noë E, Morren MA, Verslype C, Van Cutsem E, Van den Oord JJ, et al. Scleroderma-like cutaneous lesions during treatment with paclitaxel and gemcitabine in a patient with pancreatic adenocarcinoma. Review of literature. Int J Dermatol. 2018;57(9):1075–9.
Läuchli S, Trüeb RM, Fehr M HJ. Scleroderma-like drug reaction to paclitaxel (Taxol). Br J Dermatol. 2002;147(3):619–21.
Sibaud V, Leboeuf NR, Roche H, Belum VR, Gladieff L, Deslandres M, et al. Dermatological adverse events with taxane chemotherapy. Eur J Dermatology. 2016;26(5):427–43.
Winkelmann RR, Yiannias JA, Dicaudo DJ, Trotter SC, Farhey Y, Griffing WL, et al. Paclitaxel-induced diffuse cutaneous sclerosis: A case with associated esophageal dysmotility, Raynaud’s phenomenon, and myositis. Int J Dermatol. 2016;55(1):97–100.
Itoh M, Yanaba K, Kobayashi T, Nakagawa H. Taxane-induced scleroderma. Br J Dermatol. 2007;156(2):363–7.
Hassett G, Harnett P, Manolios N. Scleroderma in association with the use of docetaxel (taxotere) for breast cancer. Clin Exp Rheumatol. 2001;19(2):197–200.
Ohashi A, Minagawa A, Ashida A, Koga H, Uhara H, Okuyama R. Histopathological improvement of scleroderma induced by paclitaxel in a patient with breast cancer. J Dermatol. 2015;42(12):1198–9.
Kawakami, T., Tsutsumi, Y., & Soma Y. Limited Cutaneous Systemic Sclerosis Induced by Paclitaxel in a Patient With Breast Cancer. Arch Dermatol. 2009;145(1):97–8.
Konishi Y, Sato H, Sato N, Fujimoto T, Fukuda J, Tanaka T. Scleroderma-like cutaneous lesions induced by paclitaxel and carboplatin for ovarian carcinoma, not a single course of carboplatin, but re-induced and worsened by previously administrated paclitaxel. J Obstet Gynaecol Res. 2010;36(3):693–6.
Ketpueak T, Chanloung W, Nan KN, Pongsananurak C, Kasitanon N, Louthrenoo W. Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma. Clin Rheumatol [Internet]. 2022;41(12):3887–96. Available from: https://doi.org/10.1007/s10067-022-06364-z
Yang JQ, Dou TT, Chen XB, Min M, Cai SQ, Zheng M, et al. Docetaxel-induced scleroderma: a case report and its role in the production of extracellular matrix. Int J Rheum Dis. 2017;20(11):1835–7.
De Angelis R, Bugatti L, Cerioni A, Del Medico P, Filosa G. Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer. Clin Rheumatol. 2003;22(1):49–52.
Okada K, Endo Y, Miyachi Y, Koike Y, Kuwatsuka Y, Utani A. Glycosaminoglycan and versican deposits in taxane-induced sclerosis. Br J Dermatol. 2015;173(4):1054–8.
Kilic MO, Yalaza M, Bilgic CI, Dener C. Docetaxel-induced Scleroderma in A Breast Cancer Patient: A Case Report. J Breast Heal. 2015;11(2):95–7.
Eisenbeilss C, Weizel J WH. Scleroderma-like skin changes following administration of paclitaxel for the treatment of ovarian carcinoma]. J Dtsch Dermatol Ges. 2003;1(6):468–70.
Debien V, Petitdemange A, Bazin D, Ederle C, Nespola B, Merdji H, et al. New-onset systemic sclerosis and scleroderma renal crisis under docetaxel. J Scleroderma Relat Disord. 2021;
Ogawa T, Okiyama N, Koguchi-Yoshioka H FM. Taxane-induced scleroderma-like skin changes resulting in gangrene : A case report. J Dermatol. 2017;44(4):e54–5.
Farrant PBJ, Mortimer PS, Gore M. Scleroderma and the taxanes. Is there really a link? Clin Exp Dermatol. 2004;29(4):360–2.
Cleveland MG, Ajaikumar BS, Reganti R. Cutaneous fibrosis induced by docetaxel: A case report. Cancer. 2000;88(5):1078–81.
This work is licensed under a Creative Commons Attribution 4.0 International License.